Ambeed.cn

首页 / 抑制剂/激动剂 / 膜转运蛋白 / 质子泵 / (R)-Lansoprazole

右旋兰索拉唑 /(R)-Lansoprazole {[allProObj[0].p_purity_real_show]}

货号:A414150 同义名: 右兰索拉唑 / Dexlansoprazole;T-168390

(R)-Lansoprazole, the dextrorotatory enantiomer of lansoprazole, can irreversibly inactivate the H+/K+-stimulated ATPase pump.

(R)-Lansoprazole 化学结构 CAS号:138530-94-6
(R)-Lansoprazole 化学结构
CAS号:138530-94-6
(R)-Lansoprazole 3D分子结构
CAS号:138530-94-6
(R)-Lansoprazole 化学结构 CAS号:138530-94-6
(R)-Lansoprazole 3D分子结构 CAS号:138530-94-6
规格 价格 会员价 库存 数量
{[ item.pr_size ]}

{[ getRatePrice(item.pr_rmb, 1,1) ]}

{[ getRatePrice(item.pr_rmb_sale, 1,1) ]} {[ suihuo_tips(item.pr_am, item.pr_size) ]}

{[ getRatePrice(item.pr_rmb, 1,1) ]}

{[ getRatePrice(item.pr_rmb,item.pr_rate,1) ]} {[ suihuo_tips(item.pr_am, item.pr_size) ]}
{[ getRatePrice(item.pr_rmb, 1,1) ]}{[ suihuo_tips(item.pr_am, item.pr_size) ]} {[ getRatePrice(item.pr_rmb_sale, 1,1) ]} {[ getRatePrice(item.pr_rmb,item.pr_rate,item.mem_rate) ]} {[ getRatePrice(item.pr_rmb,1,item.mem_rate) ]} 现货 咨询 - +
购物车0 收藏 询单

(R)-Lansoprazole 纯度/质量文件 产品仅供科研

货号:A414150 标准纯度: {[allProObj[0].p_purity_real_show]}
批次查询: 批次纯度:

全球学术期刊中引用的产品

Cell, 2024, 101755. Ambeed. [ A399663 ]
EMBO J., 2024. Ambeed. [ A295334 ]
JMC, 2024, 67(20): 18265-18289. Ambeed. [ A538667 , A341145 , A117430 , A172297 ]
JMC, 2024. Ambeed. [ A210558 , A1518164 ]
Cell Death Discov., 2024, 10, 436. Ambeed. [ A384235 ]
更多 >
产品名称 Proton Pump 其他靶点 纯度
Zinc pyrithione 98+%
PF 03716556 ++++

H+/K+-ATPase, pIC50: ~6.5

98%
Lansoprazole 98%
Esomeprazole Magnesium 98%+
Rabeprazole 99%+
Ilaprazole TOPK 97%
Bafilomycin A1 ++++

H+-ATPase, IC50: 0.44 nM

95%
Pantoprazole sodium 98%
(R)-Lansoprazole 98%
Tenatoprazole 99%+
Omeprazole 98%
1. 鼠标悬停在“+”上可以显示相关IC50的具体数值。"+"越多,抑制作用越强。2. "✔"表示该化合物对相应的亚型有抑制作用,但抑制强度暂时没有相关数据。

(R)-Lansoprazole 生物活性

靶点
  • Proton Pump

描述 (R)-Lansoprazole is the R enantiomer of Lansoprazole. Lansoprazole (AG 1749) is an orally active proton pump inhibitor that suppresses gastric acid production. Additionally, Lansoprazole (AG 1749) is a potent brain-penetrating inhibitor of neutral sphingomyelinase (N-SMase), which also acts as an exosome inhibitor[1][2].
体外研究

The plasma concentrations of (R)-lansoprazole are notably elevated across all three CYP2C19 genotype groups compared to the corresponding (S)-enantiomer. In terms of AUC0-∞, Cmax, and elimination half-life, (R)-lansoprazole exhibits significantly higher values and longer durations compared to the (S)-enantiomer across all genotype groups[3].

(R)-Lansoprazole 临床研究

NCT号 适应症或疾病 临床期 招募状态 预计完成时间 地点
NCT00274339 Laryngopharyngeal Reflux Not Applicable Unknown June 2008 United States, Kentucky ... 展开 >> Commonwealth Ear, Nose & Throat Recruiting Louisville, Kentucky, United States, 40207 Contact: Marti Gardner, MSN    502-893-0159 ext 1185    mgardner@commonwealthent.com    Principal Investigator: Kenneth M Hodge, MD          Sub-Investigator: John R Morris, MD          Sub-Investigator: Donald V Welsh, MD          Sub-Investigator: Gorden T McMurry, MD          Sub-Investigator: Andrew R Gould, MD          Sub-Investigator: Keith D Forwith, PhD, MD          Sub-Investigator: Steven D Shotts, MD          Sub-Investigator: Tamalynn O'Daniel, MSN, ARNP          Sub-Investigator: Jolene H Boswell, PA-C          Sub-Investigator: Mary S McLaughlin, PA-C          Sub-Investigator: Martha L Gardner, MSN, ARNP          Sub-Investigator: Brian Walker, PA-C 收起 <<
NCT02297126 Adverse Drug Reaction Not Applicable Completed - United States, Indiana ... 展开 >> Eskenazi Health System Indianapolis, Indiana, United States, 46250 收起 <<
NCT00237679 Voice Disorders ... 展开 >> Gastroesophageal Reflux 收起 << Not Applicable Terminated(Terminated due to f... 展开 >>unding loss.) 收起 << - United States, Wisconsin ... 展开 >> University of Wisconsin Madison, Wisconsin, United States, 53792 收起 <<

(R)-Lansoprazole 参考文献

[1]Kokufu, T., et al., Effects of lansoprazole on pharmacokinetics and metabolism of theophylline. Eur J Clin Pharmacol, 1995. 48(5): p. 391-5.

[2]Huarui Zhang, et al. Advances in the discovery of exosome inhibitors in cancer. J Enzyme Inhib Med Chem. 2020 Dec;35(1):1322-1330.

[3]M Miura, et al. Pharmacokinetic differences between the enantiomers of lansoprazole and its metabolite, 5-hydroxylansoprazole, in relation to CYP2C19 genotypes. Eur J Clin Pharmacol. 2004 Nov;60(9):623-8.

(R)-Lansoprazole 实验方案

计算器
存储液制备 1mg 5mg 10mg

1 mM

5 mM

10 mM

2.71mL

0.54mL

0.27mL

13.54mL

2.71mL

1.35mL

27.07mL

5.41mL

2.71mL

(R)-Lansoprazole 技术信息

CAS号138530-94-6
分子式C16H14F3N3O2S
分子量 369.361
别名 右兰索拉唑 ;Dexlansoprazole;T-168390;TAK-390;(+)-Lansoprazole
运输蓝冰
存储条件

液体 -20°C:3-6个月-80°C:12个月

粉末 Sealed in dry,2-8°C

溶解度

DMSO: 105 mg/mL(284.27 mM),配合低频超声助溶,注意:DMSO长时间开封后,会吸水并导致溶解能力下降,请避免使用长期开封的DMSO

动物实验配方
Ambeed 相关网站 Ambeed.cn Ambeed.com
Ambeed
关于我们
联系我们
资讯中心
网站地图
产品手册
  • 批次文件查询
  • 客户支持
    技术支持
    专业术语
    缩略词释义
    质量手册
    产品咨询
    计算器
    活动政策
    订购方法
    积分商城
    活动声明
    联系我们
    400-920-2911 sales@ambeed.cn tech@ambeed.cn
    Ambeed 只为有资质的科研机构、医药企业基于科学研究或药证申报的用途提供医药研发服务,不为任何个人或者非科研性质用途提供服务。